Literature DB >> 10601050

Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs.

J Weil1, M J Langman, P Wainwright, D H Lawson, M Rawlins, R F Logan, T P Brown, M P Vessey, M Murphy, D G Colin-Jones.   

Abstract

AIMS: To determine risk factors for peptic ulcer bleeding other than non-steroidal anti-inflammatory drugs (NSAIDs). Methods-Data on possible antecedent risk factors obtained in a large case control study of 1121 patients admitted to hospitals in Glasgow, Newcastle, Nottingham, Oxford, and Portsmouth with bleeding peptic ulcers were compared with the same information obtained in 989 population controls. Data were analysed by logistic regression with the calculation of odds ratios (OR) and 95% confidence intervals (CI).
RESULTS: From a logistic regression model, oral anticoagulants (OR 7. 8; 95% CI 2.8-21.5), previous peptic ulcer (3.8; 2.6-4.9), treatment for heart failure (5.9; 2.3-13.1), oral corticosteroid use (2.7; 1. 3-4.5), treatment for diabetes (3.1; 1.2-4.3), and current smoking (1.6; 1.2-2.0) were all independent risk factors. No association was found with use of calcium channel antagonists. Odds ratios for concomitant NSAID usage were multiplicative with the exception of current smoking.
CONCLUSIONS: Some 45% of admissions for peptic ulcer bleeding in England and Wales in those aged 60 or more are calculated to be attributable to, or associated with, these accessory risk factors, which, together with those associated with aspirin or other NSAID use will account for over 80% of predisposing factors to ulcer bleeding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601050      PMCID: PMC1727776          DOI: 10.1136/gut.46.1.27

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Major upper gastrointestinal bleeding and the use of calcium channel blockers.

Authors:  J P Kelly; A Laszlo; D W Kaufman; A Sundstrom; S Shapiro
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

Review 2.  Nonassociation of adrenocorticosteroid therapy and peptic ulcer.

Authors:  H O Conn; B L Blitzer
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

3.  Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding.

Authors:  J R Laporte; X Carné; X Vidal; V Moreno; J Juan
Journal:  Lancet       Date:  1991-01-12       Impact factor: 79.321

4.  Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding.

Authors:  D W Kaufman; J P Kelly; J E Sheehan; A Laszlo; B E Wiholm; L Alfredsson; R S Koff; S Shapiro
Journal:  Clin Pharmacol Ther       Date:  1993-04       Impact factor: 6.875

5.  Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy.

Authors:  R L Savage; P W Moller; C L Ballantyne; J E Wells
Journal:  Arthritis Rheum       Date:  1993-01

6.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

7.  Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs.

Authors:  J M Piper; W A Ray; J R Daugherty; M R Griffin
Journal:  Ann Intern Med       Date:  1991-05-01       Impact factor: 25.391

8.  Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study.

Authors:  L A García Rodríguez; A M Walker; S Pérez Gutthann
Journal:  Epidemiology       Date:  1992-07       Impact factor: 4.822

9.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

Authors:  M R Griffin; J M Piper; J R Daugherty; M Snowden; W A Ray
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

10.  Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation.

Authors:  T W Meade; P J Roderick; P J Brennan; H C Wilkes; C C Kelleher
Journal:  Thromb Haemost       Date:  1992-07-06       Impact factor: 5.249

View more
  53 in total

1.  Preventing atherosclerotic events with aspirin.

Authors:  John G F Cleland
Journal:  BMJ       Date:  2002-01-12

2.  High concomitant use of interacting drugs and low use of gastroprotective drugs among NSAID users in an unselected elderly population: a nationwide register-based study.

Authors:  Rickard Ljung; Yunxia Lu; Jesper Lagergren
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

3.  Association between adherence to evidence-based guidelines for the prescription of non-steroidal anti-inflammatory drugs and the incidence of gastric mucosal lesions in Japanese patients.

Authors:  Hidetaka Tsumura; Tsuyoshi Fujita; Isamu Tamura; Yoshinori Morita; Masaru Yoshida; Takashi Toyonaga; Hidekazu Mukai; Hideto Inokuchi; Hiromu Kutsumi; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2010-05-25       Impact factor: 7.527

4.  Factors associated with the initiation of proton pump inhibitors in corticosteroid users.

Authors:  Jeffrey C Munson; Peter M Wahl; Gregory Daniel; Stephen E Kimmel; Sean Hennessy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01-25       Impact factor: 2.890

Review 5.  Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure.

Authors:  Christos V Bourantas; Huan P Loh; Nasser Sherwi; Ann C Tweddel; Ramesh de Silva; Elena I Lukaschuk; Antony Nicholson; Alan S Rigby; Simon D Thackray; Duncan F Ettles; Nikolay P Nikitin; Andrew L Clark; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

6.  Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract.

Authors:  Tae Young Oh; Gook Jun Ahn; Seul Min Choi; Byoung Ok Ahn; Won Bae Kim
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

Review 7.  Risk factors for gastrointestinal complications in aspirin users: review of clinical and experimental data.

Authors:  Felix W Leung
Journal:  Dig Dis Sci       Date:  2008-02-28       Impact factor: 3.199

8.  Do statins protect against upper gastrointestinal bleeding?

Authors:  Sinem Ezgi Gulmez; Annmarie Touborg Lassen; Claus Aalykke; Michael Dall; Alin Andries; Birthe Søgaard Andersen; Jane Møller Hansen; Morten Andersen; Jesper Hallas
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

9.  Comparative gastrointestinal safety of weekly oral bisphosphonates.

Authors:  S M Cadarette; J N Katz; M A Brookhart; T Stürmer; M R Stedman; R Levin; D H Solomon
Journal:  Osteoporos Int       Date:  2009-03-06       Impact factor: 4.507

10.  Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.

Authors:  C J Hawkey; J Naesdal; I Wilson; G Långström; A J Swannell; R A Peacock; N D Yeomans
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.